CI
Cigna Corporation · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth -5.0% ·
share flow -2.7% ·
net new positions -5.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 179 | 0 | 199.76M | $55.09B | +4 | −3 |
| Q1 2026 | 181 | +2 | 199.25M | $53.08B | +3 | −2 |
| Q4 2025 | 178 | +1 | 211.33M | $58.16B | +2 | — |
| Q3 2025 | 27 | 0 | 123.40M | $35.56B | — | −1 |
| Q2 2025 | 25 | +2 | 110.22M | $36.42B | +2 | — |
| Q1 2025 | 20 | +1 | 48.70M | $16.02B | +1 | — |
| Q4 2024 | 19 | -1 | 48.42M | $13.37B | — | −1 |
| Q3 2024 | 19 | -1 | 37.77M | $13.08B | — | −1 |
| Q2 2024 | 20 | — | 38.82M | $12.83B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 12.08M | -2.5% | $4.19B | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 12.08M | -2.5% | $4.19B | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 3 | Dodge & Cox ✦ | 8.79M | -0.7% | $3.05B | 1.7% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 5.86M | +0.4% | $2.02B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 5.86M | +0.4% | $2.02B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 3.06M | -2.3% | $1.06B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 2.40M | -7.3% | $831.51M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.41M | -8.6% | $488.80M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.41M | -8.6% | $488.80M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.41M | -8.6% | $488.80M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 1.41M | -8.6% | $488.80M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.41M | -8.6% | $488.80M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 13 | Capital World Investors ✦ | 1.21M | +1.2% | $418.27M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Glenview Capital ✦ | 1.05M | -18.7% | $364.34M | 7.7% | ▼ Trim | 2 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 576.66K | +85.6% | $199.78M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 376.86K | +71.8% | $130.56M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 323.84K | +14.6% | $112.19M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 257.59K | -10.4% | $89.24M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 222.39K | -0.4% | $77.04M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 222.39K | -0.4% | $77.04M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 50.31K | +15.9% | $17.43M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 44.97K | -80.1% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Marshall Wace ✦ | 32.97K | -82.9% | $11.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | GAMCO Investors ✦ | 15.65K | -2.1% | $5.42M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 25 | Wellington Management ✦ | 15.18K | -14.8% | $5.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 15.18K | -14.8% | $5.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 15.18K | -14.8% | $5.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Fisher Asset Management ✦ | 1.34K | -4.7% | $463,304 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Renaissance Technologies | $56.08M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,635 holders, 229.05M shares, $59.07B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.68K sh · $748,516
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology